The effect of quinicline, procaine amide and five new antiarrhythmic compounds on calciuminduced arrhythmias in the rat are described. When the compounds prevented fibrillation, the other actions of calcium on cardiac rhythm were revealed.
I
T has been well established that calcium can produce various alterations in cardiac rhythm such as fibrillation, arrest and/or bradycardia.
"
i Recently, Malinow 6 presented a standardized method for producing ventricular fibrillation in the rat by calcium injection. This method was employed in the present study to evaluate a series of anti-arrhythmic compounds which were previously found effective in the treatment of several atrial and ventricular arrhythmias in the dog. 6 During the present studies it was observed that when fibrillation was prevented other effects of calcium, particularly cardiac arrest, appeared. This report describes the effect of these compounds on calcium-induced alterations of cardiac rhythm. The compounds* studied include quinidine and procaine amide in addition to SC-3920, N-(7-isopropylaminopropyl)-a, a-diphenylacetamide hydrochloride; SC-3323, /Sdiisopropylaminoethyl -4 -phenyl -4 -tetrahyd ropy rancarboxy late hydrochloride; SC-3755, O-(4-chlorobenzyl)phenoxyacetamidine hydrochloride; SC-2919, N,X,N'-triphenyl-N'-(j8-diethylaminoethyl)urea hydrochloride; and SC-3412, /9-diethylaminoethyl-2,6-dimethyl -5,6 -dihydro -4 H -pyran -3- Both authors examined the electrocardiograms independently after the entire group of experiments was completed; to minimize personal bias, the records were evaluated without knowing the treatment. Changes in the electrocardiogram were classified for each animal as follows: no change, bradycardia, ventricular arrest, short periods of fibrillation and/or long periods of fibrillation. The distinction between short and long periods of fibrillation was arbitrary; short periods consisted of only a few ectopic beats in contrast to long periods which represented prolonged continuous runs.
Each anti-arrhythmic agent was studied at three or four dose levels using a two-fold increment in dosage. The various doses of the compounds were studied at random until a total of five to eight rats had been treated with each dose of each compound.
RESULTS
Calcium chloride uniformly produced immediate death by ventricular fibrillation in a group of ten control animals. When rats were pretreated with an effective anti-arrhythmic agent there was a decrease in the incidence of fatal ventricular fibrillation and a concomitant increase in survival, or there was fatal cardiac arrest. However, cardiac arrest was frequently preceded by a short period of ventricular fibrillation, demonstrating two of the actions of calcium in the same animal. Further, the onset of fibrillation was frequent]}' delayed and in a few cases bradycardia was the initial effect of calcium.
The actions of the anti-arrhythmic compounds were considered from two aspects: (a) the incidence of fibrillation following calcium chloride without regard to death or survival (fig. 1) ; and (b) the influence of the compounds on mortality following calcium chloride, with details as to the mode of death ( fig. 2) . The two aspects have been combined in reporting the results for each compound.
Procaine amide prevented fibrillation in all the animals pretreated with 160 mg. per Kg., but 67 per cent of these animals succumbed to cardiac arrest. No electrocardiographic changes occurred before the arrest. At 80 mg. per Kg. the fibrillation produced by calcium was preceded by an initial short period of bradycardia.
Quinidine sidfate did not reduce the incidence of fibrillation at 4 and 8 mg. per Kg., although long fibrillatory periods yielded to short periods. There was a progressive decrease in death from fibrillation even though the percentage survival did not increase until the dose reached 16 mg. per Kg.
SC-3920 was the most active compound in these experiments. It produced a progressive increase in survival with the two smallest doses. However, none of the animals survived at the highest dose, but all died of cardiac arrest after the calcium without any other electrocardiographic change.
SC-3755 did not decrease the over-all incidence of fibrillation, but reduced the severity by a shift from long to short periods. The increase in the incidence of periods of short fibrillation paralleled an increase in cardiac arrest. The percentage survival remained unchanged.
SC-3412 provided little protection against calcium fibrillation until 32 mg. per Kg. were administered. At this dose 50 per cent of the rats survived and thirty-three per cent died of cardiac arrest.
SC-2919 was one of the more active com- The animals that survived the initial injection of calcium ( fig. 2) were challenged a second time in the same manner. This resulted in death by arrest in the rats treated with SC-3920, SC-3755 and SC-2919; death by fibrillation in the rats treated with quinidine; and either by fibrillation or by arrest in the rats treated with SC-3323, SC-3412 or procaine amide.
DISCUSSION
The compounds most active in preventing calcium-induced ventricular fibrillation in the rat on a dosage basis were SC-3920, quinidine and SC-2919. Procaine amide was the least potent substance, requiring from ten to twenty times the dose of SC-3920 for a comparable effect. The effective dosages for procaine amide and quinidine in the above studies compare closely with those reported by Malinow and coworkers 6 (50-100 mg. per Kg. for procaine amide and 20 mg. per Kg. for quinidine).
The present work indicates that all seven compounds have some activity against ventricular arrhythmias in the rat. This contrasts with the observations previously reported 8 for the dog in which only quinidine, procaine amide, SC-3920 and SC-3755 had a significant effect on the ventricular tachycardia resulting from coronary ligation, and all the compounds except SC-3755 produced a reversion of atrial nutter and fibrillation to sinus rhythm. It is evident, therefore, that several experimental procedures should be used for the evaluation of anti-arrhythmic activity.
Calcium is capable of producing several alterations in cardiac rhythm, but the only effect observed in the control animals was fibrillation; the other actions were revealed only when fibrillation was prevented or delayed by the anti-arrhythmic agents. These actions of calcium on cardiac rhythm in the rat are consistent with the findings of Hoff and coworkers' in morphinized dogs, that calcium in doses of 1.29 to 3.9 raM per Kg. produces bradycardia leading to fibrillation or cardiac arrest. Their doses of calcium are comparable to the dose of calcium used in the present studies in the rat, namely 1.36 mM per Kg.
The decrease in percentage survival produced by the 8 mg. per Kg. dose of SC-3920 ( fig. 2 ) is probably associated with a combined action of calcium and SC-3920 to produce immediate cardiac arrest; SC-3920 was previously shown to be a severe cardiac depressant in dogs at 10 mg. per Kg.
SUMMARY
The actions of quinidine, procaine amide and five new compounds were studied on calcium-induced fibrillation in rats. The compounds are hydrochlorides of the following bases: SC-3920, N-(7-isopropylaminopropyl)-a,a-diphenylacetamide; SC-3323, /3-diisopropylaminoethyl -4 -phenyl -4 -tetrahydropyrancarboxylate; SC-3755, O-(4-chlorobenzyl)-phenoxyacetamidine; SC-2919, N, N , N'-triphenyl-N'-Q9-diethylaminoethyl)urea; and SC-3412, /3-diethylaminoethyl-2,6-dimethyl-5,6-dihydro-4H-pyran-3-carboxylate. All the com pounds were active in preventing calcium fibrillation. The most active on a dosage basis were SC-3920, quinidine and SC-2919. Other actions of calcium, such as cardiac arrest and bradycardia, were revealed when fibrillation was prevented by these anti-arrhythmic agents. 
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Alleged Synergism of the Sympathetic Nervous and Adrenal Medullary Systems
It has become a common theory that the adrenal medullary hormones and sympathetic neuro-effectore act synergistically and indiscriminately on regulation of blood flow. The adrenal medulla has even been designated as the "loud pedal" of the sympathetic nervous system.
Many of the inferences linking humoral and nervous actions have resulted from use of pharmacologio rather than physiologic doses of humoral agents or from nerve excitation at frequencies above the established normal rates of sympathetic impulse discharges.
Using these modern methods, Swedish physiologists have recently demonstrated that the motor control of blood vessels is much more powerful than the adrenal hormonal control under physiologic conditions. For instance, in cutaneous areas low frequency stimulation of nerves reduced blood flow 10 to 20 times more than similar excitation of adrenal nerves. Furthermore, simultaneous stimulation of the two caused no significant reinforcement of effect. No evidence of an "overflow of sympathin" was discovered.
In a careful review of previous work and that in which he participated, Celander concludes that neither medullary catechols nor circulating sympathins are of quantitative importance in regulating blood flow directly. Contrary to the "key cell" theory of Cannon & Rosenblueth (Autonomic Neuro-Effector Systems, The AlacMillan Co. N. Y. 1937) the evidence indicates that "every cell subordinate to the sympathetic nervous system makes a close contact with sympathetic; neuro fibers, and, as a matter of fact, an overlap appears to exist, so that axon ramifications from several neurons convei'ge upon each effector cell."
The action of the adrenomedullary hormone is apparently limited to cells that lack a sympathetic innervation. This explains not only their important metabolic effects within physiologic ranges, but also secondary circulatory adjustments. For example, it appeal's demonstrated that norepinephrine in a wide dosage range only constricts vessels of skeletal muscle whereas epinephrine constricts them in large doses, but dilates them in small ones. The hypothesis is favored that the latter effeots are secondary to its glycogenetic action, i.e., are really induced by the ultimate release of lactate.
After Olov Celunder, The Range of Control Exercised by the "SympathicoAdrenal System," Acta physiol. Scundinav. 32, Suppl. 32, 1954. 
